Key result
Venous thromboembolism poses significant morbidity and mortality risks, with complications including bleeding, postthrombotic syndrome, recurrence, and chronic thromboembolic pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
Venous thromboembolism carries significant morbidity and mortality risks, with chronic thromboembolic pulmonary hypertension emerging as a key complication requiring close follow-up.
Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. They pose a significant risk for morbidity and mortality. In an appropriate clinical setting, invasive interventions, including administration of thrombolytics, anticoagulation, and placement of vena cava filter, are warranted. Bleeding, postthrombotic syndrome, recurrence, and filter-associated complications are few of the complications of this disease. More recently, chronic thromboembolic pulmonary hypertension has gained clinical interest in patients with pulmonary embolism and has warranted close follow-up.
No takes yet. Share an insight, caveat, or question.
Gandhi et al. (2017) conducted a review in Venous thromboembolism. Venous thromboembolism poses significant morbidity and mortality risks, with complications including bleeding, postthrombotic syndrome, recurrence, and chronic thromboembolic pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: